Gerald V. Denis, PhD, Named Shipley Prostate Cancer Research Professor

Gerald V. Denis, PhD, has been named the Shipley Prostate Cancer Research Professor effective September 1, and will represent the molecular oncology themes of the Center. Dr. Denis has been a member of the BU faculty for 23 years, during which time he pioneered studies of the Bromodomain and ExtraTerminal (BET)... More

Cancer Center Retreat

The Cancer Center Retreat was held on February 28.  The event included the Center Director’s report, presentation of the Center’s four research programs, selected lightning talks, a presentation from the Translational Oncology Core (CTAP) and a poster session highlighting tools and resources that are available to the research community.  Retreat... More

BU and Johnson & Johnson Innovation Team Up to Fight Lung Cancer

Tuesday, June 6, 2018 Written by: Sara Rimer and Art Jahnke | Source: BUToday New Medical Campus center hopes to speed development of interventions and cures In what Boston University President Robert A. Brown envisions as a model for industry and academia collaborating to improve human health, BU has launched a five-year translational research alliance with... More

BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition

Published April 2018 Provided by: American Association for Cancer Research Publications | Source: Molecular Cancer Research Guillaume P. Andrieu and Gerald V. Denis DOI: 10.1158/1541-7786.MCR-17-0568 Abstract Transcriptional programs in embryogenesis and cancer, such as the epithelial-to-mesenchymal transition (EMT), ensure cellular plasticity, an essential feature of carcinoma progression. As effectors of signal transduction, the bromodomain and extraterminal... More

BU-CTSI Fall 2017 Pilot Awardees

Monday, March 5, 2018 Provided by: Boston University Clinical & Translational Science Institute | Source: CTSI Boston University Clinical and Translational Science Institute (BU-CTSI) is pleased to announce the recipients of the Fall 2017 Integrated Pilot Grant Program. Each awardee received $20,000 in funding. The CTSI would like to recognize the faculty who reviewed the applicants... More

Insight into chromatin therapies for breast cancer could aid personalized medicine

Wednesday, February 7, 2018 Provided by: Boston University School of Medicine | Source: Medical Xpress Most traditional chemotherapy for cancer has dangerous side effects, but new research is finding ways to develop 'targeted agents' that reduce the side effects and are better tailored to individual patient needs. While these innovations are exciting, a new study shows... More

2018 Dahod International Scholar

Friday, February 2, 2018 Kristyna Kotýnková, PhD, has been named the 2018 Dahod International Scholar. In August 2008 Shamim Dahod (CGS'76, CAS'78, MED'87) and her husband Ashraf gave $10.5 million to BUSM to establish the Shamim and Ashraf Dahod Breast Cancer Research Center, as well as endow assistant professorships and international... More

Avrum Spira Leads “Stand Up to Cancer” Dream Team

Wednesday, November 1, 2017 Written by: Sara Rimer | Source: BUToday Armed with $12 million, researchers aim for early detection of lung cancer Can lung cancer, rarely diagnosed until it’s in an advanced and deadly stage, be nipped in the bud? Avrum Spira and his team intend to find out. Spira (ENG’02), Alexander Graham Bell Professor in Health... More